United Therapeutics Corporation

Historical 13F Holders

Symbol
UTHR
CUSIP
91307C102
All holders as of
Q4 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q1 1 26.0 $13.9 k
2025 Q4 855 37.0 M $17.9 B
2025 Q3 755 41.1 M $17.2 B
2025 Q2 698 44.1 M $12.7 B
2025 Q1 692 44.4 M $13.7 B
2024 Q4 704 44.2 M $15.6 B
2024 Q3 654 44.1 M $15.8 B
2024 Q2 601 47.0 M $15.0 B
2024 Q1 558 46.5 M $10.7 B
2023 Q4 557 45.4 M $10.0 B
2023 Q3 536 44.5 M $10.0 B
2023 Q2 501 45.0 M $9.92 B
2023 Q1 527 45.7 M $10.1 B
2022 Q4 534 46.5 M $12.9 B
2022 Q3 482 45.6 M $9.56 B
2022 Q2 491 44.1 M $10.4 B
2022 Q1 449 44.1 M $7.91 B
2021 Q4 439 43.2 M $9.34 B
2021 Q3 444 44.2 M $8.15 B
2021 Q2 420 44.1 M $7.91 B
2021 Q1 415 43.6 M $7.31 B
2020 Q4 385 44.1 M $6.71 B
2020 Q3 353 42.1 M $4.26 B
2020 Q2 375 42.5 M $5.14 B
2020 Q1 328 43.1 M $4.08 B
2019 Q4 344 41.9 M $3.69 B
2019 Q3 331 41.8 M $3.33 B
2019 Q2 356 42.2 M $3.29 B
2019 Q1 402 42.9 M $5.02 B
2018 Q4 380 44.1 M $4.78 B
2018 Q3 390 44.1 M $5.62 B
2018 Q2 397 42.9 M $4.85 B
2018 Q1 396 43.8 M $4.91 B
2017 Q4 422 44.6 M $6.56 B
2017 Q3 403 43.7 M $5.13 B
2017 Q2 399 46.3 M $6.01 B
2017 Q1 439 49.8 M $6.75 B
2016 Q4 435 48.0 M $6.88 B
2016 Q3 423 48.8 M $5.75 B
2016 Q2 413 49.6 M $5.25 B
2016 Q1 424 51.2 M $5.70 B
2015 Q4 415 51.6 M $8.08 B
2015 Q3 392 51.0 M $6.70 B
2015 Q2 409 51.0 M $8.87 B
2015 Q1 387 52.4 M $9.03 B
2014 Q4 351 51.6 M $6.69 B
2014 Q3 340 53.1 M $9.17 B
2014 Q2 317 53.6 M $4.75 B
2014 Q1 328 67.6 M $7.83 B